Asia-Pacific Leads Injectable Device Expansion: Diabetes and Oncology Demand Push Regional Market to $22B by 2030, 10% CAGR
The Asia-Pacific (APAC) region is the fastest-growing segment of the injectable drug delivery devices market, outpacing North America and Europe with a projected 10% CAGR from 2024 to 2030. Valued at $12 billion in 2023, APAC’s regional market is expected to reach $22 billion by 2030, driven by rising chronic disease rates, expanding healthcare access, and a surge in biologic drug use....
0 Комментарии 0 Поделились 109 Просмотры 0 предпросмотр